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Gene expression is a multistep process starting in the cell
nucleus with the synthesis of the primary transcripts that un-
dergo several modifications (including capping, splicing, and
polyadenylation) leading to the export of the mature mRNAs
into the cytoplasm for translation into proteins. Although an
emerging view is that all the steps from transcription to trans-
lation are mechanically and functionally coupled, the proteins
that are involved in this coupled process are still poorly char-
acterized. In recent years, a growing list of proteins known to
control gene expression at the transcriptional level, named
transcriptional coregulators, have been independently shown
to play additional roles in other steps of gene expression. In
this review we compile these emerging data suggesting that a
subset of transcriptional coregulators play a major role in the
coordination of the individual steps of the gene expression
process.
GENE EXPRESSION REGULATION AND
TRANSCRIPTIONAL COREGULATORS
Transcriptional stimuli, such as steroid hormones (i.e., an-
drogens, progestins, estrogen, etc.), change the expression of
their target genes by binding and modulating the activity of
their nuclear receptors (NRs), which recognize and bind spe-
cific sequences within target gene promoters. NRs share a
signature modular structure consisting of a C-terminal ligand-
dependent transcriptional activation domain (AF-2), a central
DNA binding domain, and an N-terminal ligand-independent
transcriptional activation domain (AF-1) (55, 60). When bound to
their target promoters, and like other transcription factors, NRs
recruit coregulatory proteins termed coactivators or corepressors
that activate or inhibit transcription. Since their discovery in the
mid-1990s, the number of transcriptional coregulators has rapidly
increased to more than 150. An exhaustive list of NR coregulators
is available on the Nuclear Receptor Signaling Atlas website,
http://www.nursa.org/index.cfm. Several reviews concerning co-
regulators have been recently published (5, 14, 29, 42, 60), and we
will only briefly describe the background knowledge of their
known roles in transcription.
NR coregulators, which were identified as proteins interact-
ing with different NR domains and that can contain specific
NR-interacting motifs such as LxxLL or the FxxLF motifs, are
often present within dynamic and heterogeneous steady-state
complexes (for example, the SRC, TRAP/SMCC/Mediator/
SRB, CRSP, DRIP, and ASCOM complexes). Many coregu-
lators are most likely recruited at the promoter level as part of
these preformed complexes (14, 60, 62, 91). When present on
target promoters, transcriptional coregulators play different
roles either due to their specific enzymatic activities (e.g., ki-
nase, acetyl- or methyltransferase, or ubiquitin- or sumo-ligase
activities) or due to their ability to recruit other regulator
proteins. Certain coregulators play a crucial role in remodeling
chromatin structure by modifying histone tails or/and by pro-
moting nucleosome remodeling, in turn facilitating the access
of other proteins to the promoter. Finally, transcriptional co-
regulators recruit and stabilize the basal transcriptional ma-
chinery at the promoter, including RNA polymerase II (pol II),
leading to the formation of the transcriptional preinitiation
and initiation complexes (5, 14, 29, 42, 60). A few reports also
have suggested that activated NRs modulate transcriptional elon-
gation, although the potential coregulators involved are not well
defined (41, 48, 96). Steroid hormones lead to the relocation of
NRs to target promoters; the NRs serve as anchors for the sub-
sequent sequential recruitment of different sets of coregulators,
which are generally present in preformed but dynamic steady-
state complexes. These coregulator complexes affect various rate-
limiting transcriptional steps and lead to the assembly of the
complete processive transcriptional machinery, including the gen-
eral transcriptional factors and pol II. As described below, several
transcriptional coregulators also have been implicated in steps
that have been termed “posttranscriptional” but that are rather
now considered “cotranscriptional” steps.
NUCLEAR RECEPTOR COREGULATORS RELATED TO
PROTEINS INVOLVED IN SPLICING
Most eukaryotic genes contain protein coding information
within exons separated by noncoding sequences or introns
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(Fig. 1). Prior to translation, the intronic sequences must be
efficiently and accurately removed from the primary transcript
or precursor of mRNA (pre-mRNA). The exons have to be
joined together to form the translatable mRNA. This process,
called splicing, is performed by a large and complex machinery,
termed the spliceosome, containing 100 to 300 proteins (Fig. 1
and 2). Several reviews have described the structure of this
machinery and the mechanism of splicing (28, 43, 100). Briefly,
the spliceosome is made of five small nuclear ribonucleopro-
tein particles (snRNPs) called U1, U2, U4, U5, and U6, which
FIG. 1. Gene expression is a multistep process, and each step is made by the sequential recruitment of small preformed complexes performing
successive reactions. Transcription factors like NRs recognize response elements within target promoters and recruit transcriptional coregulators
that exist in preformed small complexes (Co. Complex). The sequential recruitment of different sets of coregulators leads to the formation of the
transcriptosome, which ultimately allows the RNA pol II (PII) to be fully processive. After the synthesis of 20 to 40 nt, the 5 end of the transcript
is methylated (cap) through the sequential action of three enzymes. This cap structure plays a role in stability and translation of the mRNA.
Similarly, after recognition of sequences at the 3 end of the gene, transcription stops (T, termination) and the transcript is cleaved upstream of
the termination site. The 3 end is modified by the addition of a polyadenylated tail (pA) that also plays a role in the stability and translation of
the mRNA. This step is made by the sequential recruitment of small preformed complexes. As soon as the primary transcript emerges from the
RNA pol II CTD, splicing regulatory sequences within exons or introns are recognized by SFs that recruit preformed small complexes (U snRNPs)
on the pre-mRNA, which leads to the formation of the spliceosome. The splicing process is in turn coupled to the export of the mRNA translated
in the cytosol.
FIG. 2. Transcriptional coregulators present within the spliceosome. SFs recognize exonic or intronic splicing regulatory sequences and help
the recognition of neighboring splice sites (5 SS and 3 SS) by recruiting the spliceosome subcomplexes or snRNPs (U1, U2, U4, U5, and U6).
Several proteins (shown within grey circles) that form part of the spliceosome are also transcriptional coregulators, which suggests that they could
be recruited through the transcriptional machinery.
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are very stable and which have been purified (27, 53, 68, 83,
108). Each of the U snRNPs contains a small structured RNA
(U1, U2, U4, U5, and U6 snRNAs) bound by 10 to 20 proteins,
seven of which (the Sm proteins) are shared by different
snRNPs. Numerous other, less stably associated splicing fac-
tors (SFs) participate in the formation of the spliceosome and
in the splicing reaction, which is performed through sequential
steps by virtue of the dynamic assembly and disassembly of
complexes on the pre-mRNA substrate.
Transcriptional coregulators and the spliceosome. One of
the initial steps in the splicing process is the recognition of the
5 splice site (SS), which is accomplished in part by the U1
snRNP and the base pairing of the U1 snRNA with the 5 SS
sequence (Fig. 2). This early U1-5 SS duplex aids the assembly
of the “prespliceosome” on the transcript and is then unwound
to allow the formation of the U6-5 SS duplex, leading to the
creation of the “active” spliceosome. Interestingly, these two
events require proteins that also can act as transcriptional
coregulators.
p54nrb (p54 nuclear RNA binding protein) and PSF (poly-
pyrimidine tract-binding protein-associated splicing factor) are
two highly homologous RNA binding proteins that form a
heterodimer and that likely play similar roles. These two pro-
teins have been suspected to be involved in both transcription
and splicing (92). It was reported that p54nrb and PSF (which
contains an FXXLF motif) can directly interact with the an-
drogen receptor (AR) and/or with other transcriptional co-
regulators. We and others have shown that they modulate NR
transcriptional activity (3, 35, 58). Recently, it was reported
that p54nrb and PSF directly interact with the 5 SS and that
this interaction occurs within large complexes that contain pol
II and snRNPs (39). Since p54nrb and PSF directly interact
with the pol II carboxy-terminal domain (CTD), these coregu-
lators could serve as a “molecular link” between the transcrip-
tional machinery, the 5 SS recognition on the transcript, and
the splicing machinery (18, 39).
p68 and p72 are two highly homologous proteins that form
a heterodimer and that contain a DEAD-box domain charac-
teristic of RNA helicase activities. The RNA helicase activity is
required for unwinding RNA duplexes between two different
RNAs or within RNA secondary structures (87). Many studies
identified p68 and p72 as components of the spliceosome,
although their function was only recently clarified (27, 53, 68,
83, 108). Indeed, p68 and p72 were shown to interact with the
U1-5 SS duplex to unwind it, allowing the U6-5 SS associa-
tion and the formation of the active spliceosome (51). The
essential role of p68 in this process is underlined by the fact
that depletion of this protein leads to accumulation of a pre-
spliceosome complex (51). In addition, many studies have
demonstrated the importance of p68 and p72 in transcription;
in particular, both proteins contain an LXXLL motif and di-
rectly interact with NRs, and p68 was shown by chromatin
immunoprecipitation to be recruited to a steroid-regulated
promoter (19, 62, 89). These data, together with the fact that
p68 directly interacts with the pol II CTD (89), suggest that p68
(and probably p72) also could be a “molecular link” between
the transcriptional machinery and the recognition and eventual
processing of the transcript in the active spliceosome at the 5
SS, reinforcing the observations that the splicing events occur-
ring at the 5 SS are strongly connected to transcription (39, 46,
51, 95).
Another early stage in spliceosome assembly involves the 3
SS which depends on the recognition of the branch point
sequence (BPS) by the mammalian branch point binding pro-
tein (mBBP) and of the polypyrimidine tract (PY) by the U2
auxiliary factors U2AF65 and U2AF35 (Fig. 2). Once bound to
the transcript, these proteins facilitate the association of the
U2 snRNP at the 3 end of the intron through the base pairing
of the U2 snRNA on the BPS. Interestingly, several proteins
participating in the recognition of the 3 end of the intron also
have been identified within transcriptional complexes.
For instance, mBBP was identified as a potential transcrip-
tional regulator that interacts with the transcriptional elonga-
tion factor CA150 and the TET family proteins (24, 106). It
was proposed that the function of mBBP in splicing could be
coupled to transcriptional elongation (24). In this respect, it is
important to underline that the recognition of the BPS by
mBBP is facilitated by the simultaneous recognition of the PY
tract by U2AF65 (Fig. 2). Interestingly, several proteins struc-
turally related to U2AF65 have been recently implicated in
transcription. For instance, PUF60, first identified based on its
functional and structural homology with U2AF65 (78), was
later identified as “FBP-interacting repressor,” a protein that
modulates TFIIH factor activity (50). Moreover, CAPER was
reported to be a protein that interacts with the estrogen re-
ceptor (ER) and is able to coactivate its transcriptional activity
(37). This protein, also known as CC1.3, is highly homologous
to the SF U2AF65 and was purified recently as a spliceosome
component capable of affecting the splicing reaction (2, 27, 83).
We recently identified another U2AF65-related protein,
CAPER, and we showed that both CAPER and CAPER are
NR coactivators that enter the splicing process via recruitment
to the transcriptional machinery by NRs (16).
Finally, several proteins of the SF3 complex, which is a
multisubunit component of the U2 snRNP, have been identi-
fied within transcriptional complexes. SF3a120 and SF3b130
were purified as part of several transcriptional complexes (9,
57, 97), and the SF3b14b protein was recently cloned as an ER
coregulator (74, 75). Altogether, these observations suggest
that several proteins could be potential molecular links be-
tween transcription, 3 SS recognition, and U2 snRNP recruit-
ment.
The U5 snRNP enters the spliceosome after the U1 and U2
snRNPs as part of a tri-snRNP (U4/U6.U5 snRNP) preas-
sembled complex and plays a critical role in the spliceosome
rearrangement which leads to the catalytic steps of splicing.
One of the U5 snRNP components, the U5 snRNP p102 pro-
tein containing LXXLL motifs, was recently identified as an
AR-interacting protein that also is a transcriptional coregula-
tor (26, 107). Interestingly, PRP4 kinase, another LXXLL mo-
tif-containing protein, has been found in a complex containing
the U5 snRNP p102 and the transcriptional coregulators N-
CoR and BRG1 (13). Finally, the U5 snRNP p200 helicase,
one of the U5 snRNP helicases driving the structural spliceo-
some rearrangement, shares extensive homology to the NR
coregulator ASC-1 p200, containing LXXLL motifs (38).
Spliceosome rearrangement leads to the release of some
proteins and the recruitment of new ones, such as SKIP (ski
oncogene-interacting protein). SKIP is associated with the spli-
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ceosome, and SKIP-interacting proteins are identified as U5
snRNP components (27, 52, 53, 68, 83, 108). SKIP also inter-
acts with and modulates the transcriptional activity of tran-
scription factors such as VDR, the vitamin D receptor (6, 104).
Interestingly, a SKIP mutant results in the accumulation of
unspliced transcripts generated from a VDR-responsive mini-
gene, supporting the hypothesis that the transcriptional coac-
tivator SKIP could play a role in the transformation of the
mature spliceosome into the active spliceosome (52, 53, 65,
104).
The examples provided in the above section clearly demon-
strate that several transcriptional coregulators are found within
the spliceosome in which they are thought to play specific roles.
Prior to discussing the functional aspects of this connection, we
will describe a series of transcriptional coregulators that are
functionally or structurally related to the splicing factors of the
SR family and the hnRNP family of proteins and which appear
to participate in spliceosome assembly and in the regulation of
RNA splicing.
Transcriptional coregulators and splicing factors. The splic-
ing sequences described above (5 SS, 3 SS, BPS, and PY) are
short degenerate consensus sequences as shown in Fig. 2.
Therefore, “false” or “cryptic” SSs are found particularly in
long primary transcripts. An important question is how the
splicing machinery distinguishes the true SSs from the cryptic
ones. One explanation resides in the action of specific SFs able
to distinguish regulatory sequences within and around genuine
and “false” exons. When bound to such sequences, SFs act
either as splicing enhancers, reinforcing the recognition of
neighboring SSs (Fig. 2), or as splicing silencers, masking
neighboring SSs. As discussed below, one action of SFs is to
modulate the selection of SSs (or splicing decisions), a mech-
anism known as alternative splicing and which leads to the
production of multiple different mRNAs from one pre-mRNA.
In the following section we discuss the transcriptional coregu-
lators that are structurally or functionally related to the SFs of
the SR and the hnRNP families and which play an important
role in the SS selection and regulate splicing decisions (Table
1).
Pre-mRNAs, also called heterogeneous nuclear RNAs
(hnRNAs) due to their size heterogeneity and cellular loca-
tion, form densely packed ribonucleoprotein complexes known
as heterogeneous nuclear ribonucleoprotein particles (hnRNPs)
by associating with hnRNP proteins. hnRNP proteins are in-
volved in all aspects of mRNA metabolism from transcription
to translation and even to degradation (44). There are about 20
major hnRNP proteins named from A1 to U and many others
that are less abundant. A common feature revealed by primary
sequence analysis of multiple hnRNP proteins is a typical mod-
ular structure in which one or more RNA binding domains are
associated with other (auxiliary) domains containing still
poorly defined functions. Three major types of RNA binding
domains have been identified to date: (i) the RNA recognition
motif (RRM) consisting of a 90-amino-acid sequence, (ii) the
RGG box characterized by closely spaced Arg-Gly-Gly repeats,
and (iii) the K-homology (KH) motif, a stretch of about 45
amino acids first identified in hnRNP K.
Several KH domain-containing proteins, like hnRNP K, are
involved in both splicing and transcription (8). For instance,
the KH domain protein Sam68, involved in several “posttran-
scriptional” steps, was recently identified as interacting with
the transcriptional coregulator CBP/p300 and shown to have
TABLE 1. Transcriptional coregulators structurally or functionally related to splicing factors
Protein family RNA bindingdomain Name Comment
hnRNP KH mBBP The essential splicing factor mBBP/SF1 is also a transcriptional corepressor.
ASC-1 p50 Component of the transcriptional ASC-1 complex and affects splicing decisions.
RGG hnRNP U/SAFA Associates and modulates the activity of NR and binds to the nuclear matrix.
1 RRM HET/SAFB Links transcriptional and splicing machineries; binds to nuclear matrix.
TLS Belongs to the TET family involved in transcription and splicing.
EWS Belongs to the TET family.
TAFII68 Belongs to the TET family.
RTA RNA binding protein interacting with and modulating the ER.
PERC/PGC-1 Selective transcriptional coregulator of ER; related to PGC-1 (see below).
2 RRMs CoAA Affects the activity of several transcriptional factors and splicing decisions.
PSF Splicing factor involved in modulation of NR activity.
p54nrb Related to PSF.
3 RRMs SHARP Transcriptional coregulator purified in the spliceosome.
SR TRAP150 Associates with the TRAP complex and colocalizes with splicing factors.
1 RRM PGC-1 NR coactivator; affects splicing decisions.
PRC PGC-1-related coactivator.
2 RRMs CAPER Affects NR transcriptional activity and splicing decisions.
CAPER Belongs with CAPER to a U2AF65-related protein family.
RNA helicase p68 Interacts with and modulates ER activity; it is also an essential splicing factor.
p72 Related to p68.
ASC-1 p200 ASC-1 complex component; similar to the p200 helicase of the U5 snRNP.
DP103 Coregulator of the steroidogenic factor 1, present in the SMN complex.
DP97 ER coregulator.
Others SAPs Some spliceosome-associated proteins are present in transcriptional complexes.
p102 U5 snRNP Interacts with the AR.
SKIP Vitamin D receptor transcriptional coregulator purified in the spliceosome.
PRP4kinase Associates with U5 snRNP proteins and transcriptional coregulators.
MEP50 Within the methylosome complex, acts also as a transcriptional coregulator.
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potent transcriptional repression activity (30). The KH domain
protein mBBP, which plays an important role in the recogni-
tion of the BPS, was identified as a potential transcriptional
corepressor (24, 105). Finally, a KH domain-containing pro-
tein, p50 ASC-1, was recently identified in the ASC-1 tran-
scriptional complex; we showed that this protein can affect
splicing decisions (2, 38).
Two functionally related hnRNP proteins, hnRNPU/SAF-A,
containing an RGG box and an LXXLL motif, and HET/
SAF-B, containing an RRM, interact with and modulate the
activity of NRs (17, 72). Because these proteins bind the nu-
clear matrix, DNA, RNA, and pol II CTD, they have been
proposed to serve as structural links between the nuclear ar-
chitecture and transcript synthesis and maturation (see below).
A similar role could be played by the proteins of the “TET”
family, composed of the highly homologous RRM-containing
proteins EWS, TLS, and TAFII68, which act at both the tran-
scriptional and the splicing levels (7, 61, 79).
While CoAA contains two N-terminal RRMs and shows
similarities with the hnRNP-like proteins PSF and p54nrb de-
scribed above, it was identified as a protein interacting with the
transcriptional coregulator TRBP/ASC-2. CoAA enhances the
transcriptional activity of several transcription factors, and we
reported elsewhere that CoAA also affects splicing decisions
(2–4, 36). Recently, other RRM-containing proteins have been
cloned as NR-interacting proteins. For instance, RTA, which is
homologous to the splicing factor FOX-1, was identified as an
ER-interacting protein (71). PERC/PGC1-/ERRL1 was in-
dependently cloned by two laboratories showing that this
RRM-containing protein interacts with and modulates the
transcriptional activity of NRs (45, 49). Finally, SHARP, con-
taining several RRMs, acts as a transcriptional coregulator and
copurifies with splicing complexes (93, 108).
The SR protein family is defined as RNA binding proteins
that contain arginine-serine-rich (RS) domains. The presence
of RS domains is a marker for RNA splicing function, since
proteins containing this domain usually are involved in splicing
(90). SR proteins act early in the splicing pathway and aid in
the recognition of the 5 and 3 SSs. Interestingly, several
transcriptional coregulators contain SR domains. For instance,
TRAP150, a component of the TRAP transcriptional complex,
contains an RS domain and colocalizes with other SR splicing
factors within characteristic speckles (94). The NR coregulator
PGC-1, containing an LXXLL motif and an RS domain, was
identified early as a PPAR coactivator and was shown to be
involved in splicing (63). A new NR transcriptional coregula-
tor, PRC (PGC-1-related coactivator), containing LXXLL and
RS motifs, was recently identified, although it has not yet been
shown to function in RNA splicing (1). As mentioned above,
the two transcriptional coregulators CAPER and CAPER,
related to the U2AF65 SF, contain RS domains and affect
splicing decisions (16). Finally, the general p52 coregulator, a
component of the PC4 transcriptional complex, was shown to
interact with the SR splicing factor ASF/SF2 and to impact
splicing decisions (23).
Another interesting class of proteins associated with the
splicing process is the family of ATP-dependent RNA heli-
cases. These proteins use the energy from ATP hydrolysis
either to rearrange inter- or intramolecular RNA structures or
to dissociate RNA-protein complexes. Such dynamic rear-
rangements are fundamental for many steps in the life of RNA
molecules (87). For instance, multiple helicases have been
implicated in correct recognition of pre-mRNA sequences dur-
ing spliceosome formation, during the rearrangement of the
spliceosome, or in regeneration of snRNPs between rounds of
splicing. Interestingly, several of the NR transcriptional co-
regulators mentioned above belong to the RNA helicase fam-
ily, including p68, p72, and ASC-1 p200 (see above). Other
RNA helicases, including DP97 and DP103, interact with NRs
and modulate their transcriptional activity (76, 82). The RNA
helicase A mediates the association of the transcriptional co-
regulator CBP with RNA pol II (66).
TRANSCRIPTIONAL COREGULATORS AND THE
COORDINATION OF STEPS IN THE GENE
EXPRESSION PROCESS
The preceding section, summarized in Table 1, illustrates the
large number of important transcriptional coregulators struc-
turally and/or functionally related to proteins involved in
“posttranscriptional” steps. This could reflect the fact that a
given protein, often multifunctional, plays unrelated roles in
the cell. In the following section, we will review results that
suggest that different steps of the gene expression process
should be considered to be “cotranscriptional” (rather than
“posttranscriptional”); several of these steps impact each
other. In particular, we will summarize data demonstrating
that the implication of some transcriptional coregulators (de-
fined in part as functional proteins recruited to promoters by
DNA-bound transcription factors) in splicing depends directly
on their implication in transcription, suggesting that the same
molecules are engaged in sequential transcriptional and RNA
processing events and act as “coupling” proteins.
Cotranscriptional maturation of transcripts. The synthesis
of an mRNA is an immensely complicated process. Each step
in the pathway, including transcription, capping, splicing, and
polyadenylation, is carried out by complicated molecular ma-
chineries (Fig. 1). Because experiments using in vitro systems
indicated that each of the major steps can be carried out in
isolation, it was initially assumed that the machineries respon-
sible for each step are distinct and function independently in
distinct nuclear compartments. However, many recent struc-
tural and cytological studies provided numerous pieces of ev-
idence that these steps take place simultaneously and are in-
timately coupled and, in particular, that SS selection and intron
removal can take place on the nascent transcript (33, 99).
Biochemical experiments with cotranscriptional mRNA pro-
cessing have focused on the role of the RNA pol II CTD. It is
now widely accepted that the pol II CTD can act as a platform
for nascent transcript maturation. This conclusion is based on
the fact that the CTD associates with RNA 5 capping en-
zymes, 3-end-processing factors, and various splicing factors.
Moreover, truncation of the CTD inhibits in vivo capping and
3-end processing and leads to a severe impairment of splicing;
other experiments demonstrate that pol II CTD enhances
RNA processing reactions. It is believed that the reversible
interactions between the pol II CTD and RNA processing
factors localize those factors close to their RNA substrates (25,
40, 54, 59, 84, 103). In this regard, it is important to underline
that several coregulators that we discussed above have been
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shown to directly interact with the pol II CTD. These include
SAF-A, SAF-B, TLS, EWS, PSF, p54nrb, p68, p72, and PGC-1
(see above). Such examples could provide clues as to how the
transcriptional and splicing machineries could communicate
through the pol II CTD.
As summarized above, various factors purified in transcrip-
tional complexes seem to play a role in splicing and, inversely,
factors first described as involved in splicing appear to play a
role in transcription, indicating that these two temporally and
spatially linked events share common factors. Another dem-
onstration of the interconnection between these two processes
came from Kornblihtt and coworkers, who demonstrated that
the promoter identity can impact splicing decisions (11). Korn-
blihtt and coworkers proposed a model to explain how tran-
scriptional processes can impact splicing decisions based on
the concept that the time required to make a transcript can
affect the ability of the splicing machinery to recognize splice
sites and exons. The demonstration that the speed of pol II in
synthesis of a transcript impacts the way in which the transcript
is matured clearly reinforces the “cotranscriptional” nature of
RNA processing (12, 25, 70, 85, 86).
Functional and biological roles of “coupling” proteins. On
average, a typical human gene contains eight introns and nine
exons, which together average about 30,000 nucleotides (nt) in
length. An average intron is over 3,000 nt, and an internal exon
is only 150 nt. Therefore, on average, more than 80% of the
pre-mRNA will be removed during the splicing process by
elimination of the introns (25, 34, 110). In some cases, introns
comprise up to 99% of the pre-mRNA. For example, the
dystrophin gene encodes a 3-million-nt-long pre-mRNA that
gives rise to only 12,000 nt of mature mRNA after the removal
of 78 introns (80). The nebulin gene is comprised of 183 exons
spanning 249 kb of genomic DNA. Since the start codon is in
exon 3 and the stop codon is in exon 183, about 360 SSs must
be correctly defined to allow the removal of 180 introns with
not a single nucleotide error that would alter the open reading
frame (15). Since the SSs are short degenerate consensus se-
quences, it is a challenge to understand how the splicing ma-
chinery can recognize exons that are sometimes very small and
awash in huge introns. The fact that the splicing decisions are
made coordinately with the synthesis of the transcript adds an
additional level of complexity to this process. pol II elongates
transcripts with an average rate of 1 to 2 kb/min, which means
that one average intron can be synthesized in 1 or 2 minutes
and the next one can be made less than 2 minutes later. In this
context, the first-appearing 5 SS easily could be erroneously
assembled with the second-appearing 3 SS of the adjacent
intron (25, 69, 110). Obviously, a series of highly structured and
coordinated events are required to precisely remove each of
the introns during the synthesis of the nascent transcripts. This
process may be aided by the action of specific transcriptional
coregulators that play an additional nuclear “structural” role.
Indeed, the nucleus is a membrane-bounded organelle that
contains the machineries for gene expression steps. It is be-
lieved that the nucleus has a kind of skeleton (nuclear matrix),
a complex molecular scaffold that binds genomic DNA, RNAs,
and specific proteins. It has been proposed that a subset of
proteins like hnRNPU/SAF-A or HET/SAF-B that are re-
cruited by transcriptional factors to promoters, that are at-
tached to the nuclear matrix, and that are involved in splicing
could play a role in the structural assembly of the different
gene expression machineries (10, 67). An increasing number of
specialized domains and subnuclear organelles enriched in
specific factors have been identified within the nucleus (109).
Since several nuclear compartments are defined by their en-
richment in certain specific factors (e.g., speckles containing
splicing factors), a function of a subset of transcriptional co-
regulators could be to facilitate communication and exchange
between such compartments; this has been proposed for the
AR-interacting protein ANT-1, also known as p102 U5
snRNP, described in a preceding section (26, 107). Therefore,
a subset of transcriptional coregulators could permit the as-
sembly and the communication of machineries and/or sub-
nuclear domains within the nucleus, while others could facili-
tate the kinetics of the various transcriptional steps.
Indeed, if some of the proteins required for the splicing
process are recruited prior to or during transcription and not
after it has been initiated, full spliceosome assembly will occur
more rapidly on the nascent RNA chain. Thus, when a tran-
scriptional signal stimulates its target gene promoter, the abil-
ity of such a signal to promote the recruitment of “coupling”
proteins would improve the kinetics of full mature transcript
production. Such a function could be possible for coregulators
like p54nrb, PSF, p68, p72, SAPs, and U2AF65-related pro-
teins that play a role in the recognition of SSs (see above).
Nevertheless, it is hard to conceive how a transcription factor
could recruit simultaneously the many proteins necessary for
transcription as well as the proteins required for splicing of an
RNA transcript. Rather, our current concept is that different
transcription factor molecules would be recruited in a sequen-
tial manner on their target promoter, so that different sets of
proteins and “coupling” proteins, once locally enriched, could
play a role in the recycling of other proteins or of subcom-
plexes; this could be the case for SKIP (see above). Supporting
this possibility, it is believed that no more than one spliceo-
some can assemble on a transcript at a given time and that the
spliceosome subcomplexes undergo extensive recycling (53,
99). How spliceosome recycling is achieved between successive
introns, either in a given transcript or between successive tran-
scripts, remains an unanswered question. Interestingly, acti-
vated NRs have been reported to interact with proteins that
play a role not only in the building of the spliceosome as
described above but also with proteins that play a role in the
formation of spliceosome snRNP subcomplexes. For instance,
two proteins, PRMT5 and MEP50, components of the methy-
losome complex that methylates the Sm proteins of the snRNP
complexes, were shown to modulate androgen-dependent tran-
scription (32). Moreover, DP103 and the RNA helicase A
interact with the survival motor neuron protein SMN involved
in the assembly and regeneration of snRNPs and were shown
to regulate transcription as described above. Although the
initial steps of snRNP assembly take place in the cytosol, it is
tempting to speculate that the presence of some snRNP as-
sembly proteins within the nucleus plays a role in recycling
spliceosome subcomplexes and that the recruitment of such
proteins by transcription factors would improve the kinetics
and the coordination of the recycling process in the vicinity of
the regulated gene.
The splicing machinery must remove several introns (182 in
the case of the nebulin primary transcripts). Importantly, a
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splicing error that adds or removes even one single nucleotide
disrupts the open reading frame of the mRNA. It is now clear
that strong quality control steps exist to ensure that mRNA is
appropriately processed (98). An emerging view of this quality
control process is that early steps of the pathway allow the
recruitment of proteins that are crucial for downstream events.
Therefore, if an early step is not performed correctly and some
of the proteins necessary for the next step are missing, this will
lead to the arrest of the process and the destruction of the
nascent transcript. Such a mechanism is particularly well illus-
trated by the molecular connection between transcription elon-
gation and either capping or 3-end formation. If transcription
initiation occurs correctly, RNA pol II allows the recruitment
of the capping complex involved in the 5-end maturation of
the transcript (Fig. 1). In turn, this complex “retains” pol II
after the synthesis of a 20- to 24-nt-long transcript until the
capping complex has accomplished its task (40, 54). In other
words, a correct transcriptional initiation process allows cap-
ping that in turn allows elongation of transcription. Similarly, a
strong interdependency exists between transcription termina-
tion and 3-end processing of the transcript, since pol II allows
the recruitment of 3-end-processing factors that in turn con-
trol termination of transcription (81). Similarly, the implication
of transcriptional coregulators in splicing could add another
quality control checkpoint, since splicing would occur only if
some of the proteins described in Fig. 2 were correctly re-
cruited. Supporting the existence of such a checkpoint, it has
recently been demonstrated that splicing signals can be trans-
mitted to transcription either in an early stage of transcrip-
tional initiation or during elongation. It is proposed that sam-
pling of the nascent RNA by the U1 snRNA enhances
transcription; the recruitment of snRNPs to the transcriptional
elongation complex somehow increases its efficiency (21, 22,
46, 56, 95, 110). Therefore, it can be postulated that the ap-
propriate assembly of the transcriptional machinery allows
proper construction of the spliceosome, so that when it is
correctly assembled on the transcript, it in turn allows the
transcriptional machinery to proceed. In addition to this qual-
ity control, proteins regulating transcription could also partic-
ipate in splicing regulation.
In mammalian lineage, the abundance of introns (seven to
eight per gene on average) coupled with poor conservation of
SSs allows an increasing number of alternative splicing events.
Alternative splicing that results in the ligation of differential 5
and 3 SSs allows a single gene to produce multiple mRNAs
that encode proteins with different functions. Between 30%
and 70% of the human genes generate multiple mRNAs by
alternative splicing of their primary transcripts, and 80% of
alternative splicing results in changes in the encoded protein,
making this mechanism one of the important sources of human
proteome diversity (34). The biological importance of this
mechanism is illustrated by the genes involved in cell death,
since, from a single gene involved in this cellular program,
alternative splicing leads to the production of protein isoforms
having either pro- or antiapoptotic effects (102).
Considering the strong impact of splicing decisions on the
biological functions of the gene products, alternative splicing
must be finely regulated. As mentioned above, it is known that
SFs, like SR and hnRNP proteins, can recognize sequences
within transcripts (Fig. 1 and 2) and modulate splicing choices.
When bound to these sequences, SFs can either mask or aid
the recognition of weak neighboring SSs. Increasing evidence
suggests a role for transcriptional regulators in alternative
splicing regulation. Indeed, the nature of the spliced variants
produced by a reporter gene depends on the nature of the
promoter driving the gene; the splicing decisions also can be
affected by the transcription elongation speed (11, 12, 77, 85,
86, 88). As discussed above, elongation speed can affect the
time left for the recognition of splice sites. Moreover, exons
are not only recognized by splice site recognition. Instead,
exons are defined by pairing either across introns or across
exons, multiple sequences recognized by splicing factors in a
concerted set of weak protein-RNA and protein-protein inter-
actions that either do or do not result in exon recognition and
inclusion. By slowing polymerase in the region of a transcript
with an alternative exon, these weak interactions may be fa-
vored, leading to inclusion. Finally, in transcripts with large
introns where exons are found initially, there is a second step
of exon juxtapositioning that must occur, presumably through
protein-protein interactions. The CTD becomes an ideal dock-
ing platform for these interactions, and again this could be
regulated through the elongation speed.
A subset of transcriptional coregulators may also have
evolved to regulate the quantitative enhancement of mRNA
production as well as in determining the eventual alternative
splicing decisions. Using alternatively spliced reporter genes
controlled by promoters responsive to steroid hormones, we
demonstrated that these hormonal transcriptional stimuli si-
multaneously control the transcriptional rate of their target
genes and the nature of the spliced variants produced by these
genes (2–4). We and others have also demonstrated that many
of the transcriptional coregulators described in Table 1 affect
splicing decisions (2–4, 23, 31, 63, 65, 104). Moreover, these
splicing effects mediated by transcriptional coregulators were
in some cases shown to be promoter dependent (2–4, 63, 104).
For instance, the PPAR coregulator PGC-1 affects splicing
decisions selectively on products synthesized from a PPAR-
regulated promoter (63). We recently demonstrated that the
estrogen receptor coregulator CAPER selectively affects the
splicing of products synthesized from estrogen-regulated pro-
moters (16). Finally, we demonstrated that the coregulator
CoAA affects splicing decisions in a promoter-dependent man-
ner and that the engagement of CoAA in transcription has
consequences in splicing (2, 3). Altogether, these results dem-
onstrate that select proteins important for RNA splicing deci-
sions appear to depend on their recruitment by the transcrip-
tional machinery. Certain “classical” SFs could be recruited
“directly” onto the nascent RNA transcript whereas others
might be incorporated earlier within the transcriptional ma-
chinery. Therefore, we propose that transcriptional coactiva-
tors not only participate in mRNA syntheses but also provide
a prime mechanism by which transcriptional signals influence
the nature (exon content) of their target gene products.
CONCLUSIONS
In this review we have compiled data that shows that NR
transcriptional coregulators are structurally or functionally re-
lated to proteins involved in splicing and that some of these
coregulators are actually part of the spliceosome. These ob-
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servations suggest that a subset of NR coregulators act as
dual-function “coupling” proteins between transcription and
splicing. These coupling proteins allow a spatial and temporal
coordination between transcription and splicing, providing the
molecular bases for a quality control checkpoint and for tran-
scriptional stimuli to control not only the quantity, but also the
“nature” (exon content), of their target gene products.
Steps other than transcription, capping, polyadenylation,
and splicing also are coupled in the gene expression process.
Indeed, it is now thought that all these steps even could impact
mRNA export and translation. The strong interconnection
among the different machineries involved in the gene expres-
sion process is illustrated by the results of Wolffe and Meric,
who demonstrated that the history of a transcript in the nu-
cleus affects its fate in the cytoplasm (101). In this regard, it is
tempting to speculate that the initial transcriptional stimuli
allow the recruitment of coregulator proteins that will follow
and control the fate of their target gene products until their
degradation.
Although we focused our review on NR coregulators, it is
important to underline that most of these coregulators partic-
ipate with other types of DNA binding transcription factors,
and of course, many other transcription factors have been
shown to affect splicing (20, 47, 64, 73). It is likely that the
results of studies of the NR signaling pathway can and will be
extended to other transcriptional signaling pathways.
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